Anteris Technologies Global Corp. (ASX:AVR)
7.35
+0.38 (5.45%)
Sep 12, 2025, 3:35 PM AEST
ASX:AVR Market Cap
ASX:AVR has a market cap or net worth of 265.06 million as of September 12, 2025. Its market cap has decreased by -19.10% in one year.
Market Cap
265.06M
Enterprise Value
225.39M
Revenue
3.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.35
Market Cap Chart
Since June 27, 2011, ASX:AVR's market cap has increased from 985.19K to 265.06M, an increase of 26,804.35%. That is a compound annual growth rate of 48.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 265.06M | -10.82% |
| Dec 31, 2024 | 297.22M | -12.90% |
| Dec 29, 2023 | 341.26M | 10.57% |
| Dec 30, 2022 | 308.62M | 114.65% |
| Dec 31, 2021 | 143.78M | 548.70% |
| Dec 22, 2020 | 22.16M | -62.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.19B |
| Pro Medicus | 31.05B |
| Cochlear | 19.66B |
| Sonic Healthcare | 11.22B |
| Ramsay Health Care | 7.72B |
| Ansell | 4.91B |
| Telix Pharmaceuticals | 4.88B |
| Mesoblast | 2.96B |